Azacitidine
- Product NDC
- 16714-578
- 11-digit product format
- 167140578
- Labeler code
- 16714
- Product ID
- 16714-578_ee4ad9f3-8ded-53f0-e053-2995a90ae065
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- NorthStar RxLLC
- Application
- ANDA207475
- Marketing category
- ANDA
- Marketing start
- 2022-11-18
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-578-01 | 16714057801 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16714-578-01) | 2019-01-09 | 0000-00-00 | No | No | Current |